As a result, this study discovered that elevated levels of c-Myc in cancer cells result in newly activated “Myc target genes”, such as p53, for cell cycle arrest at the G2/M phase followed by apoptosis to remove undesirable or abnormal cells before continuing the cell cycle progression. The gene discussed is MYC; the disease is cancer.